Over the past decade, drug companies have been heavily marketing the sale of so-called testosterone replacement therapy as a treatment for the signs of normal male aging, despite a lack of proven benefits and evidence of serious health risks. According to a recent news article from Commercial Appeal, a jury has awarded one plaintiff over $140 million in a product liability lawsuit filed after popular testosterone replacement therapy drug, AndroGel, caused him to have a massive heart attack.
This case was filed in federal district court located in Chicago and the defendant was AbbVie, a major drug manufacture and maker of AndroGel. The break down of the damages was $140,000 in compensatory damages and $140 million in punitive damages. Continue reading